My watch list
my.bionity.com  
Login  

Alzheimer's Disease

News Alzheimer's Disease

  • Genetic markers linking risk for type 2 diabetes and Alzheimer's identified

    Certain patients with type 2 diabetes (T2D) may have specific genetic risk factors that put them at higher risk for developing Alzheimer's disease (AD), according to a study conducted at the Icahn School of Medicine at Mount Sinai and published recently in Molecular Aspects of Medicine. Under the le more

  • Diabetes medication reduces dementia risk

    Treating people with type 2 diabetes, also known as "age-related diabetes" with antidiabetics reduces their risk for Alzheimer’s and other types of dementia. The risk is most significantly reduced by the drug pioglitazone. Researchers of the German Center for Neurodegenerative Diseases (DZNE) draw t more

  • Evotec's partner Roche provides initial update from Phase IIb trial in Alzheimer's disease

    Evotec AG was updated today by its partner Roche on the initial results of the Phase IIb trial with Sembragiline (RG1577, EVT302), a MAO-B inhibitor for the treatment of Alzheimer's disease ("AD"). In this study, Sembragiline failed to demonstrate benefit on the primary endpoint (Alzheimer's Disease more

All news on alzheimer's disease

Publications Alzheimer's Disease

All publications on alzheimer's disease

Market studies Alzheimer's Disease

  • Exelon (Alzheimer’s disease) – Analysis and Forecasts to 2022

    Introduction GlobalData’s pharmaceuticals report, “Exelon (Alzheimer’s disease) – Analysis and Forecasts to 2022” provides Exelon global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales perf more

  • Alzheimer's Disease Global Clinical Trials Review, H2, 2012

    Introduction GlobalData's clinical trial report, “Alzheimer’s Disease Global Clinical Trials Review, H2, 2012" provides data on the Alzheimer’s Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Alzheimer’s Disease. It includes a more

  • LY2062430 (Alzheimer’s disease) – Analysis and Forecasts to 2022

    Introduction GlobalData’s pharmaceuticals report, “LY2062430 (Alzheimer’s disease) – Analysis and Forecasts to 2022” provides LY2062430 global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sale more

All market studies on alzheimer's disease

Websites Alzheimer's Disease

Medivation

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat critically ill patients with serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critical more

Genizon BioSciences | Genetic Analysis, SNP Genotyping, Genetic Services, Genome Wide Association St

 Home | Contact Us | Subscribe to our News | Site Map | Français News February 25, 2009 Speid & Associates partners with Genizon BioSciences to reduce attrition rates of new drug compounds (PDF) February 7, 2008 Genizon BioSciences Collaborating With London Genetics To Enhance Gene Discovery Findin more

ir_news_17Mar2010.html

>   HOME >   CONTACT CORPORATE Profile Leadership In the News Careers RESEARCH Technology Market Indications Publications PRODUCT DEVELOPMENT Development Status Davunetide intranasal Davunetide intravenous Pre-clinical Partnering INVESTOR RELATIONS News Releases Investment Highlights Shareholder Rep more

All websites on alzheimer's disease
Related topics
Definition

Alzheimer's disease

Alzheimer's disease Alzheimer's disease (AD), also called Alzheimer disease, and simply known as Alzheimer's, is a neurodegenerative disease that, in its most common form, is found in people over the age of 65. Approximately 24 million people ... more

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE